ea0029oc9.1 | Endocrine Tumours & Translation | ICEECE2012
Hadoux J.
, Leboulleux S.
, Al Ghuzlan A.
, Borget I.
, Caramella C.
, Chougnet C.
, Young J.
, Dumont F.
, Deschamps F.
, Schlumberger M.
, Baudin E.
Malignant pheochromocytoma and paraganglioma (PPGLs) are rare diseases with a heterogeneous behaviour. 131I-MIBG therapy and the cyclophosphamide-dacarbazine-vincristine chemotherapy regimen (CVD) constitute the most popular options in the metastatic setting. We have investigated the antitumor effect of temozolomide (TMZ), in patients with metastatic PPGLs. Efficacy was primary endpoint, safety and identification for prognosis factors of response were secondary endpoints.<...